COLL FY 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M

Gross Profit

$1M87.6% margin

Operating Income

-$94M-5498.7% margin

Net Income

-$94M-5504.1% margin

EPS (Diluted)

$-3.88

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$78M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$162M

Total Liabilities

$27M

Stockholders' Equity

$135M

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$1M	-$171,000	+976.0%
Operating Income	-$94M	-$27M	-249.7%
Net Income	-$94M	-$27M	-245.5%